Probiotics in Pediatric Liver Disease

Area of Science:

• Gastroenterology and Hepatology
• Microbiology
• Pediatric Medicine

Background:

• The gut-liver axis describes the intricate relationship between gut bacteria and liver health.
• Probiotics, live beneficial microorganisms, are explored for various health conditions.
• Limited clinical data exist for probiotic efficacy in pediatric nonalcoholic fatty liver disease.

Purpose of the Study:

• To review the current evidence on probiotic use in pediatric liver diseases.
• To assess the safety and potential benefits of probiotics in children with liver conditions.

Main Methods:

• Literature review of randomized-controlled trials and clinical studies.
• Analysis of probiotic effects in nonalcoholic fatty liver disease, necrotizing enterocolitis, and other liver conditions.
• Evaluation of probiotic safety in pediatric populations, including infants and post-transplant patients.

Main Results:

• Only two randomized-controlled trials specifically investigate probiotics for pediatric nonalcoholic fatty liver disease.
• Probiotics may reduce necrotizing enterocolitis and chronic liver disease associated with total parenteral nutrition.
• Positive outcomes are reported in cystic fibrosis and familial hypercholesterolemia, suggesting potential in other liver diseases.

Conclusions:

• Probiotics are generally safe and well-tolerated in children and infants.
• Robust evidence for probiotic benefits in pediatric liver diseases is currently lacking.
• Large, prospective, randomized clinical trials are essential to establish the efficacy of probiotics in pediatric liver conditions.